Scabivax Contagious pustular dermatitis (Orf) vaccine Suspension for skin scarification
Scabivax Contagious pustular dermatitis (Orf) vaccine Suspension for skin scarification
Not authorised
- Orf virus, Live
Product identification
Medicine name:
Scabivax Contagious pustular dermatitis (Orf) vaccine Suspension for skin scarification
Active substance:
- Orf virus, Live
Target species:
-
Sheep
Route of administration:
-
Skin scarification
Product details
Active substance and strength:
-
Orf virus, Live100.00/other1.00Dose
Pharmaceutical form:
-
Cutaneous suspension
Withdrawal period by route of administration:
-
Skin scarification
-
Sheep
-
Meat and offal8week
-
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI04AD01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Ireland
Package description:
- 1 x 50 dose applicator pack consisting of a plastic vial and integral applicator. The applicator consists of wire prongs inserted into a base cap, the protruding tips protected by a seal cap, and covered by an outer cap. The vial contains 1.8 ml of vaccine.
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Intervet (Ireland) Limited
Marketing authorisation date:
Manufacturing sites for batch release:
- Schering-Plough Limited
Responsible authority:
- Health Products Regulatory Authority
Authorisation number:
- VPA10996/256/001
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
English (PDF)
Download Published on: 3/05/2024
How useful was this page?:
